NCT03218943

Brief Summary

Background and Rationale : Mechanical ventilation is an essential component of the care of patients with respiratory failure.Biphasic positive Airway Pressure (BiPAP) and Airway Pressure release ventilation (APRV) are relatively new modes of mechanical ventilation which can be used in treatment of patients with impaired oxygenation.The effect of using BiPAP and APRV modes on reducing the physiological dead space had not been previously investigated. The investigators hypothesize that using APRV mode will decrease physiological dead space more than BiPAP mode in the mechanically ventilated critically ill patients. Objectives : To assess the physiological dead space with each mode. To assess lung mechanics during the use of the two modes. To assess the effectiveness of ventilation during the use of the two modes. Study population \& Sample size : Sixty adult patients more than 18 years old who are mechanically ventilated patients with P/F ratio less than 300. This sample size was calculated based on the assumption that APRV will decrease dead space by 20% with alpha error 0.05 and power 80%. The mean and Standard deviation of the volume of the dead space assessed in a previous study using BIPAP was 40 Study Design : A randomized controlled non-blinded study with cross-over design. In the Trauma and surgical ICU at 185-Hospital (Kasr Alainy Hospitals). Methods : All mechanically ventilated patients in Trauma and surgical ICU at 185-Hospital (Kasr Alainy Hospitals) will start on pressure controlled ventilation mode (PCV) with inspiratory pressure achieving tidal volume 6-8 ml/kg for 2 hours then they will be randomized into one of the two study groups the BIPAP group or the APRV group . Possible Risk (s) to study population : By adjusting the ventilator parameters properly and continuous monitoring of the patients in the study, there will be no risk facing the patients. Outcome parameter (s): Primary outcome: Physiological dead space will be measured in the two groups after 30 minutes. Secondary outcomes

  • Physiological dead space after 3 hours.
  • PO2/FiO2 ratio.
  • Peak airway and Mean airway pressures.
  • PCO2 and PH.
  • Dynamic compliance.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Aug 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 11, 2017

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 17, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

August 25, 2017

Completed
7 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

August 22, 2017

Status Verified

August 1, 2017

Enrollment Period

7 days

First QC Date

July 11, 2017

Last Update Submit

August 19, 2017

Conditions

Keywords

BiPAPAPRVPhysiological dead spacevolumetric capnographyARDSimpaired oxygenationICUMechanical ventilation

Outcome Measures

Primary Outcomes (1)

  • Physiological dead space

    percentage of vd/vt ( dead space volume/ Tidal volume ) which is measured by volumetric capnography included in the metabolic module on General Electric ventilator (Engstrom Carestation, GE Health care, USA).

    after 30 min. on each mode ( APRV and BiPAP )

Secondary Outcomes (7)

  • Physiological dead space.

    after 3 hours on each mode ( APRV and BiPAP ).

  • PO2/FiO2 ratio

    after 30 min. and 3 hours on each mode ( APRV and BiPAP ).

  • Peak airway pressure

    after 30 min. and 3 hours on each mode ( APRV and BiPAP ).

  • Mean airway pressure

    after 30 min. and 3 hours on each mode ( APRV and BiPAP ).

  • Dynamic compliance

    after 30 min. and 3 hours on each mode ( APRV and BiPAP ).

  • +2 more secondary outcomes

Study Arms (2)

APRV ventilation

ACTIVE COMPARATOR

They will start on APRV mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 4:1 for 3 hours Then, they will return to the initial settings ( PCV ) for 2 hours . then, they will be switched into BiPAP mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 1:1 for 3 hours. Then left for ventilation according to the preference of the physician in charge.

Device: APRV ventilation mode

BiPAP ventilation

ACTIVE COMPARATOR

They will start on BiPAP mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 1:1 for 3 hours. Then, they will return to the initial settings ( PCV ) for 2 hours . then, they will be switched into APRV mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 4:1 for 3 hours. Then left for ventilation according to the preference of the physician in charge.

Device: BIPAP ventilation moood

Interventions

They will start on APRV mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 4:1 for 3 hours

APRV ventilation

start on BiPAP mode with high pressure (Phi) 20 cmH2O , low pressure(Plo) 5 cmH2O with I:E ratio ( Phi phase: Plo phase ratio ) 1:1 for 3 hours

BiPAP ventilation

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults above 18 years old.
  • Patients who are recently mechanically ventilated ( within 48 hours ).
  • Patients with P/F ratio less than 300.

You may not qualify if:

  • patients with COPD or pneumothorax.
  • Patients with acute lung injury.
  • patients with Emphysema and Emphysematous bullae .
  • patients with broncho-pleural fistula.
  • patients with severe hemodynamic instability (on IV Noradrenaline \> 0.8 mic/kg/min).
  • patients with cardiomyopathy , and those with stenotic valvular diseases.
  • Patients with increased intracerebral pressure.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesia , intensive care and pain management -faculty of medicine Cairo Uni.- kasr Alainy Hospitals.

Cairo, Egypt

RECRUITING

Related Publications (5)

  • Haitsma JJ, Lachmann RA, Lachmann B. Lung protective ventilation in ARDS: role of mediators, PEEP and surfactant. Monaldi Arch Chest Dis. 2003 Apr-Jun;59(2):108-18.

    PMID: 14635498BACKGROUND
  • Hormann C, Baum M, Putensen C, Mutz NJ, Benzer H. Biphasic positive airway pressure (BIPAP)--a new mode of ventilatory support. Eur J Anaesthesiol. 1994 Jan;11(1):37-42.

    PMID: 8143712BACKGROUND
  • Baum M, Benzer H, Putensen C, Koller W, Putz G. [Biphasic positive airway pressure (BIPAP)--a new form of augmented ventilation]. Anaesthesist. 1989 Sep;38(9):452-8. German.

    PMID: 2686487BACKGROUND
  • Verscheure S, Massion PB, Verschuren F, Damas P, Magder S. Volumetric capnography: lessons from the past and current clinical applications. Crit Care. 2016 Jun 23;20(1):184. doi: 10.1186/s13054-016-1377-3.

    PMID: 27334879BACKGROUND
  • Anderson CT, Breen PH. Carbon dioxide kinetics and capnography during critical care. Crit Care. 2000;4(4):207-15. doi: 10.1186/cc696. Epub 2000 Jul 12.

    PMID: 11094503BACKGROUND

Related Links

MeSH Terms

Interventions

Continuous Positive Airway Pressure

Intervention Hierarchy (Ancestors)

Positive-Pressure RespirationRespiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Ahmed Elkahwagy

    Department of Anesthesia , intensive care and pain management at kasr Alainy hospitals -faculty of medicine - Cairo Uni. - Egypt

    STUDY DIRECTOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Model Details: A randomized controlled study with cross-over design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator ,Dr. Ahmed Samir Elkahwagy

Study Record Dates

First Submitted

July 11, 2017

First Posted

July 17, 2017

Study Start

August 25, 2017

Primary Completion

September 1, 2017

Study Completion

September 1, 2017

Last Updated

August 22, 2017

Record last verified: 2017-08

Data Sharing

IPD Sharing
Will not share

Locations